GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » YoY EPS Growth

Burning Rock Biotech (Burning Rock Biotech) YoY EPS Growth : 26.42% (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Burning Rock Biotech's YoY EPS Growth for the quarter that ended in Sep. 2023 was 26.42%.

Burning Rock Biotech's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $-0.23.


Burning Rock Biotech YoY EPS Growth Historical Data

The historical data trend for Burning Rock Biotech's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech YoY EPS Growth Chart

Burning Rock Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EPS Growth
Get a 7-Day Free Trial -342.23 63.59 -91.62 -14.16 -11.66

Burning Rock Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.20 19.63 33.25 52.01 26.42

Burning Rock Biotech YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Burning Rock Biotech's YoY EPS Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EPS Growth (A: Dec. 2022 )
=(Earnings per Share (Diluted) (A: Dec. 2022 )-Earnings per Share (Diluted) (A: Dec. 2021 ))/ | Earnings per Share (Diluted) (A: Dec. 2021 ) |
=(-1.341--1.201)/ | -1.201 |
=-11.66 %

Burning Rock Biotech's YoY EPS Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EPS Growth (Q: Sep. 2023 )
=(Earnings per Share (Diluted) (Q: Sep. 2023 )-Earnings per Share (Diluted) (Q: Sep. 2022 )) / | Earnings per Share (Diluted) (Q: Sep. 2022 )) |
=(-0.234--0.318)/ | -0.318 |
=26.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Burning Rock Biotech YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Burning Rock Biotech (Burning Rock Biotech) Business Description

Traded in Other Exchanges
Address
No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005
Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.